Covered recipient · General Payments record
SHARON M ONDREYCO
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$3,714.02
- Reported across 216 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $212.07 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $62.53 | 3 |
| Celgene Corporation | $23.84 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $20.11 | 1 |
| Tempus AI, Inc | $19.18 | 1 |
| Incyte Corporation | $18.16 | 1 |
| Mirati Therapeutics, Inc. | $18.05 | 1 |
| Blueprint Medicines Corporation | $17.26 | 1 |
| Acerta Pharma LLC | $16.75 | 1 |
| SpringWorks Therapeutics, Inc. | $16.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $16.75 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104203163 | CMS |
| Blueprint Medicines Corporation | $17.26 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147439918 | CMS |
| Celgene Corporation | $23.84 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101155184 | CMS |
| Incyte Corporation | $18.16 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141233797 | CMS |
| Mirati Therapeutics, Inc. | $18.05 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117171890 | CMS |
| PFIZER INC. | $16.62 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131727541 | CMS |
| PFIZER INC. | $18.65 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131292634 | CMS |
| PFIZER INC. | $27.26 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131283681 | CMS |
| PROGENICS PHARMACEUTICALS, INC. | $20.11 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128514101 | CMS |
| SpringWorks Therapeutics, Inc. | $16.19 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085806827 | CMS |
| Tempus AI, Inc | $19.18 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150171154 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.